PEPTIDE VACCINES

The disclosure relates to polypeptides and pharmaceutical compositions comprising polypeptides that find use in the prevention or treatment of cancer, in particular gastric cancer, lung cancer, melanoma and bladder cancer. The disclosure also relates to methods of inducing a cytotoxic T cell respons...

Full description

Saved in:
Bibliographic Details
Main Authors Megyesi, Mónika, Csiszovszki, Zsolt, Molnár, Levente, Lisziewicz, Julianna, Somogyi, Eszter, Toke, Eniko, Toth, József, Lorincz, Orsolya, Pántya, Katalin
Format Patent
LanguageEnglish
Published 04.01.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The disclosure relates to polypeptides and pharmaceutical compositions comprising polypeptides that find use in the prevention or treatment of cancer, in particular gastric cancer, lung cancer, melanoma and bladder cancer. The disclosure also relates to methods of inducing a cytotoxic T cell response in a subject or treating cancer by administering pharmaceutical compositions comprising the peptides, and companion diagnostic methods of identifying subjects for treatment. The peptides comprise T cell epitopes that are immunogenic in a high percentage of patients.
Bibliography:Application Number: US202318311117